Acute Myeloid Leukemia with Myelodysplasia-related Changes

• CLINICAL_TRIALS trial_result · 2026-03-06
  Clinical Trial Update: CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia [Phase 2]

  Phase 2 trial update evaluating CPX-351 in combination with glasdegib for newly diagnosed acute myeloid leukemia with myelodysplasia-related…

• CLINICAL_TRIALS trial_result · 2026-01-29
  Clinical Trial Update: Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed [Phase 1, Phase 2]

  Phase 1/2 study of guadecitabine plus atezolizumab in adults with advanced myelodysplastic syndrome or chronic myelomonocytic leukemia that …

• CLINICAL_TRIALS trial_result · 2025-12-23
  Clinical Trial Update: CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old [Phase 2]

  Phase 2 trial update of CPX-351 for secondary acute myeloid leukemia in patients under 60; the study is currently active but not recruiting,…

• CLINICAL_TRIALS trial_result · 2025-12-19
  Clinical Trial Update: Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes [Phase 2]

  Phase 2 trial evaluating adding pomalidomide to the standard liposomal daunorubicin/cytarabine chemotherapy in newly diagnosed acute myeloid…

• CLINICAL_TRIALS trial_result · 2025-11-20
  Clinical Trial Update: VYxeoS Liposomal Italian Observational Study iN the Real Practice

  A real-world observational study in Italy evaluating Vyxeos (CPX-351) for acute myeloid leukemia and its subtypes has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-05-21
  Clinical Trial Update: Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant [Phase 1, Phase 2]

  A Phase 1/2 trial evaluating daratumumab plus donor lymphocyte infusion in relapsed acute myeloid leukemia after stem cell transplantation w…

• CLINICAL_TRIALS trial_result · 2023-06-09
  Clinical Trial Update: High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant [Phase 2]

  Phase 2 clinical trial evaluating high-dose cyclophosphamide, tacrolimus, and mycophenolate mofetil to prevent graft-versus-host disease in …

• CLINICAL_TRIALS trial_result · 2014-02-20
  Clinical Trial Update: Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]

  Phase 2 trial evaluating decitabine as maintenance therapy after standard treatment in adults with previously untreated acute myeloid leukem…